Request Deal Involvement

Blade Therapeutics and Biotech Acquisition terminated its $352m merger.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Covington & Burling

legal advisors to financial advisors

Covington & Burling

Barclays

financial advisors

Barclays

Cantor Fitzgerald

financial advisors

Cantor Fitzgerald

Latham & Watkins

legal advisors

Latham & Watkins

Simpson Thacher & Bartlett

legal advisors to financial advisors

Simpson Thacher & Bartlett

Lazard

financial advisors

Lazard

Ellenoff Grossman & Schole

legal advisors

Ellenoff Grossman & Schole

or

Principals

SPRIM GLOBAL INVESTMENT

bidder

SPRIM GLOBAL INVESTMENT

BLADE THERAPEUTICS

target

BLADE THERAPEUTICS

BIOTECH ACQUISITION COMPANY

bidder

BIOTECH ACQUISITION COMPANY

PFIZER VENTURES

bidder

PFIZER VENTURES

OSAGE UNIVERSITY PARTNERS

bidder

OSAGE UNIVERSITY PARTNERS

DEERFIELD MANAGEMENT COMPANY

bidder

DEERFIELD MANAGEMENT COMPANY

MPM CAPITAL

bidder

MPM CAPITAL

BRISTOL MYERS SQUIBB COMPANY

bidder

BRISTOL MYERS SQUIBB COMPANY

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Blade Therapeutics and Biotech Acquisition terminated its $352m merger.